Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Aveo
Aveo
After surprise FDA win, Aveo reverts to normal as partner splits, giving back unwanted asset
Fierce Biotech
Mon, 03/15/21 - 11:01 am
Aveo
FDA
CANbridge
AV-203
Novartis dumps worldwide rights to an Aveo drug, and the little biotech is not happy with them
Endpoints
Tue, 07/3/18 - 11:18 am
Novartis
Aveo
GDF15
AV-380
Aveo soars as long-beleaguered cancer drug nears approval
Fierce Biotech
Sat, 06/24/17 - 09:23 am
Aveo
Europe
tivozanib
kidney cancer
Aveo, Astellas end pact to develop cancer drug Tivozanib
Yahoo/Reuters
Fri, 02/14/14 - 11:57 am
Aveo
Astellas
tivozanib
colon cancer
AVEO to meet with FDA about tivozanib
Bizjournals.com
Thu, 02/28/13 - 11:33 am
FDA
Aveo
tivozanib
kidney cancer
Roche Leads Pack for Upcoming FDA Approvals
Motley Fool
Wed, 01/9/13 - 12:20 pm
FDA
drug approvals
Roche
T-DM1
Aveo
Delcath
Navidea Biopharmaceuticals
Lymphoseek
tivozanib
chemostat
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
8 Intriguing Small Cap Biotechnology Companies For Your Consideration
Seeking Alpha
Mon, 08/20/12 - 10:32 am
Affymax
Alnylam
Arena Pharmaceuticals
Aveo
BioTime
ChemoCentryx
Emergent BioSolutions
Clovis Oncology
Enzon
Forest Labs
Geron
ViroPharma
Targacept
GSK
Pfizer
Santarus
PDL Biopharma
Infinity Pharmaceuticals
Nektar
Six Disruptive Biotech Stocks
Motley Fool
Sat, 08/18/12 - 03:51 pm
Dendreon
Seattle Genetics
Immunogen
Roche
Vertex Pharmaceuticals
Aveo
Ariad Pharmaceuticals
Isis Pharmaceuticals
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3
Seeking Alpha
Mon, 05/28/12 - 11:21 am
ASCO
Synta
Sunesis
Arqule
Cyclacel
Aveo
Bristol-Myers Squibb
AVEO Oncology initiates Phase 1 study of AV-203
Yahoo
Wed, 05/23/12 - 12:10 pm
Aveo
AV-203
cancer
monoclonal antibodies
ASCO '12 Abstract Dump: Cancer Stocks in Focus
TheStreet.com
Thu, 05/17/12 - 10:35 am
ASCO
Array Biopharma
Exelixis
Pharmacyclics
Onyx
Seattle Genetics
Aveo
Ariad Pharmaceuticals
Arqule
Oncothyreon
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
10 Biotech Stocks Positively Correlated To Volatility
Seeking Alpha
Thu, 03/22/12 - 11:35 am
Amyris
Aveo
China Biologic
Chelsea Therapeutics
Pluristem
Spectrum Pharmaceuticals
Questcor
Theravance
Vical
Zalicus